An Astellas Pharma drug designed to deal with a brand new goal has obtained long-awaited FDA approval for a uncommon type of gastrointestinal most cancers, making it the primary remedy in a brand new class of oncology medication. The regulatory determination introduced Friday considerations the first-line therapy of adults with superior circumstances of gastric or gastroesophageal junction (GEJ) adenocarcinoma. These […]
